Literature DB >> 10661571

Characterization of the adherent cells developed in Dexter-type long-term cultures from human umbilical cord blood.

M Gutiérrez-Rodríguez1, E Reyes-Maldonado, H Mayani.   

Abstract

We have previously shown that when human umbilical cord blood (UCB) cells are cultured in standard Dexter-type long-term cultures (D-LTC), adherent cells develop forming a discrete net on the bottom of the culture flask. The identity of such cells, however, has not been defined. Accordingly, the major goal of the present study was to characterize the adherent cells developed in standard UCB D-LTC. Cultures were established from 14 UCB samples and from nine bone marrow (BM) samples, as controls. Both UCB and BM cultures were initiated with the same number of mononuclear cells (MNC) (2.5 x 10(6) MNC/ml). After three weeks in culture, adherent cell numbers in UCB D-LTC were 24%-30% of the numbers found in BM cultures. More than 90% of the adherent cells in UCB D-LTC expressed the acid phosphatase enzyme, whereas no alkaline phosphatase-positive cells were observed. This was in contrast to BM D-LTC, in which alkaline and acid phosphatase were expressed by 60%-75% and 20%-45% of the adherent cells, respectively. Immunochemical analysis showed that CD61 (osteoclast marker) and Factor VIII (endothelial cell marker) were not expressed by the adherent cells developed in UCB cultures. Interestingly, the majority of such cells expressed CD1a (dendritic cell marker), CD14, CD68 and CD115 (antigens mainly expressed by macrophagic cells). When the cultures were supplemented with the recombinant cytokines epidermal growth factor, basic fibroblast growth factor, platelet-derived growth factor or granulocyte-macrophage colony-stimulating factor (GM-CSF), only GM-CSF had a significant positive effect on adherent cell number. In order to test for some functional properties of the adherent cells developed in culture, production of stem cell factor (SCF), interleukin 6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha) was assessed. IL-6 and TNF-alpha showed elevated levels in UCB D-LTC, whereas SCF levels were always below detection. Finally, analysis of fibroblast progenitors (fibroblast colony-forming units [CFU-F]) showed that these cells were present in BM samples (6 CFU-F/10(5) MNC) and were totally absent in UCB samples. Taken together, the results of the present study indicate that the vast majority of the adherent cells developed in standard UCB D-LTC belong to the macrophage lineage and that fibroblasts seem to be absent. Interestingly, the high proportion of CD1a+ cells suggests that dendritic cells are also present in these cultures.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10661571     DOI: 10.1634/stemcells.18-1-46

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  16 in total

Review 1.  Mesenchymal stem cells. A potential source for skeletal repair.

Authors:  W E Fibbe
Journal:  Ann Rheum Dis       Date:  2002-11       Impact factor: 19.103

2.  Chondrogenesis from umbilical cord blood cells stimulated with BMP-2 and BMP-6.

Authors:  Cristiane Sampaio de Mara; A S S Duarte; A R Sartori-Cintra; A C M Luzo; S T O Saad; I B Coimbra
Journal:  Rheumatol Int       Date:  2012-01-12       Impact factor: 2.631

3.  Bone marrow and umbilical cord blood human mesenchymal stem cells: state of the art.

Authors:  Arianna Malgieri; Eugenia Kantzari; Maria Patrizia Patrizi; Stefano Gambardella
Journal:  Int J Clin Exp Med       Date:  2010-09-07

4.  What is the future for cord blood stem cells?

Authors:  E A de Wynter
Journal:  Cytotechnology       Date:  2003-03       Impact factor: 2.058

5.  In vitro biomimetic engineering of a human hematopoietic niche with functional properties.

Authors:  Paul E Bourgine; Thibaut Klein; Anna M Paczulla; Takafumi Shimizu; Leo Kunz; Konstantinos D Kokkaliaris; Daniel L Coutu; Claudia Lengerke; Radek Skoda; Timm Schroeder; Ivan Martin
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-04       Impact factor: 11.205

6.  Stem cells for reprogramming: could hUMSCs be a better choice?

Authors:  Paulina Duya; Yuhong Bian; Xiaoqian Chu; Yanjun Zhang
Journal:  Cytotechnology       Date:  2012-09-12       Impact factor: 2.058

7.  Bone marrow mesenchymal stem cells can be mobilized into peripheral blood by G-CSF in vivo and integrate into traumatically injured cerebral tissue.

Authors:  Jun Deng; Zhong-min Zou; Tao-li Zhou; Yong-ping Su; Guo-ping Ai; Jun-ping Wang; Hui Xu; Shi-wu Dong
Journal:  Neurol Sci       Date:  2011-06-16       Impact factor: 3.307

Review 8.  Stem and progenitor cells in human umbilical cord blood.

Authors:  Myoung Woo Lee; In Keun Jang; Keon Hee Yoo; Ki Woong Sung; Hong Hoe Koo
Journal:  Int J Hematol       Date:  2010-06-25       Impact factor: 2.490

9.  MePR: a novel human mesenchymal progenitor model with characteristics of pluripotency.

Authors:  Marco Miceli; Gianluigi Franci; Carmela Dell'Aversana; Francesca Ricciardiello; Francesca Petraglia; Annamaria Carissimo; Lucia Perone; Giuseppe Maria Maruotti; Marco Savarese; Pasquale Martinelli; Massimo Cancemi; Lucia Altucci
Journal:  Stem Cells Dev       Date:  2013-05-24       Impact factor: 3.272

10.  Comparison of cytokine expression in mesenchymal stem cells from human placenta, cord blood, and bone marrow.

Authors:  Jong Ha Hwang; Soung Shin Shim; Oye Sun Seok; Hang Young Lee; Sang Kyu Woo; Bong Hui Kim; Hae Ryong Song; Jae Kwan Lee; Yong Kyun Park
Journal:  J Korean Med Sci       Date:  2009-07-29       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.